Achillion Pharmaceuticals competitors

Achillion Pharmaceuticals Competitors include Adaptive Biotechnologies, WaferGen Biosystems, F-star Biotechnology and Spring Bank Pharmaceuticals.
Add company...
Achillion Pharmaceuticals
Achillion Pharmaceuticals
Achillion Pharmaceuticals is engaged in the discovery, development and commercialization of treatments for infectious diseases.
Adaptive Biotechnologies
Adaptive Biotechnologies
Adaptive Biotechnologies offers research and diagnostic tools for scientists and clinicians involved in genomic immunology.
WaferGen Biosystems
WaferGen Biosystems
Innovative single-cell analysis and clinical research solutions.
F-star Biotechnology
F-star Biotechnology
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Founding Date
Founding Date
1998
Founding Date
2009
Founding Date
2003
Founding Date
2006
Founding Date
2002
Type
Type
Public
Type
Private
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
New Haven, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Locations
Fremont, US HQ
Luxembourg, LU
Locations
Cambridgeshire, GB HQ
Wien, AT
Locations
Hopkinton, US HQ
Milford, US
Employees
Employees
81
Employees
2844% increase
Employees
N/A
Employees
882% increase
Employees
15
Valuation ($)
Valuation ($)
442.2 m
Valuation ($)
1.1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
131.3 m
Twitter followers
Twitter followers
1.1 k
Twitter followers
2.3 k
Twitter followers
294
Twitter followers
486
Twitter followers
1.2 k

Financial

Net income
Net income
($85.2m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
(£1.5m) (FY, 2017)
Net income
($27.7m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 206.2m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 9.4m (about 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 539m
Total funding raised
$ 56.9m
Total funding raised
$ 57.3m
Total funding raised
$ 14.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

Adaptive Biotechnologies
HQ
Seattle, US
Employees
284↑ 4% increase

Adaptive Biotechnologies offers research and diagnostic tools for scientists and clinicians involved in genomic immunology.

View company
WaferGen Biosystems
HQ
Fremont, US

Innovative single-cell analysis and clinical research solutions.

View company
F-star Biotechnology
HQ
Cambridgeshire, GB
Employees
88↑ 2% increase

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

View company
Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
15

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company